179 related articles for article (PubMed ID: 28748001)
1. A long-range interactive DNA methylation marker panel for the promoters of HOXA9 and HOXA10 predicts survival in breast cancer patients.
Park SM; Choi EY; Bae M; Choi JK; Kim YJ
Clin Epigenetics; 2017; 9():73. PubMed ID: 28748001
[TBL] [Abstract][Full Text] [Related]
2. HOXD13 methylation status is a prognostic indicator in breast cancer.
Zhong Z; Shan M; Wang J; Liu T; Xia B; Niu M; Ren Y; Pang D
Int J Clin Exp Pathol; 2015; 8(9):10716-24. PubMed ID: 26617782
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer.
Zhang L; Yan DL; Yang F; Wang DD; Chen X; Wu JZ; Tang JH; Xia WJ
Oncotarget; 2017 Jul; 8(28):45496-45505. PubMed ID: 28525377
[TBL] [Abstract][Full Text] [Related]
4. Large-scale analysis of
Croes L; Beyens M; Fransen E; Ibrahim J; Vanden Berghe W; Suls A; Peeters M; Pauwels P; Van Camp G; Op de Beeck K
Clin Epigenetics; 2018; 10():51. PubMed ID: 29682089
[TBL] [Abstract][Full Text] [Related]
5. Survival differences of CIMP subtypes integrated with CNA information in human breast cancer.
Wang H; Yan W; Zhang S; Gu Y; Wang Y; Wei Y; Liu H; Wang F; Wu Q; Zhang Y
Oncotarget; 2017 Jul; 8(30):48807-48819. PubMed ID: 28415743
[TBL] [Abstract][Full Text] [Related]
6. CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer.
Stefansson OA; Hermanowicz S; van der Horst J; Hilmarsdottir H; Staszczak Z; Jonasson JG; Tryggvadottir L; Gudjonsson T; Sigurdsson S
BMC Cancer; 2017 Jul; 17(1):469. PubMed ID: 28679371
[TBL] [Abstract][Full Text] [Related]
7. Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma.
Kurscheid S; Bady P; Sciuscio D; Samarzija I; Shay T; Vassallo I; Criekinge WV; Daniel RT; van den Bent MJ; Marosi C; Weller M; Mason WP; Domany E; Stupp R; Delorenzi M; Hegi ME
Genome Biol; 2015 Jan; 16(1):16. PubMed ID: 25622821
[TBL] [Abstract][Full Text] [Related]
8. Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer.
Tommasi S; Karm DL; Wu X; Yen Y; Pfeifer GP
Breast Cancer Res; 2009; 11(1):R14. PubMed ID: 19250546
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide methylome and chromatin interactome identify abnormal enhancer to be risk factor of breast cancer.
Wang Y; Hao DP; Li JJ; Wang L; Di LJ
Oncotarget; 2017 Jul; 8(27):44705-44719. PubMed ID: 28621677
[TBL] [Abstract][Full Text] [Related]
10. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival.
Conway K; Edmiston SN; May R; Kuan PF; Chu H; Bryant C; Tse CK; Swift-Scanlan T; Geradts J; Troester MA; Millikan RC
Breast Cancer Res; 2014 Oct; 16(5):450. PubMed ID: 25287138
[TBL] [Abstract][Full Text] [Related]
12. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
[TBL] [Abstract][Full Text] [Related]
13. HOXA9 methylation and blood vessel invasion in FFPE tissues for prognostic stratification of stage I lung adenocarcinoma patients.
Lissa D; Ishigame T; Noro R; Tucker MJ; Bliskovsky V; Shema S; Beck JA; Bowman ED; Harris CC; Robles AI
Lung Cancer; 2018 Aug; 122():151-159. PubMed ID: 30032824
[TBL] [Abstract][Full Text] [Related]
14. Pattern of RECK CpG methylation as a potential marker for predicting breast cancer prognosis and drug-sensitivity.
Shi G; Yoshida Y; Yuki K; Nishimura T; Kawata Y; Kawashima M; Iwaisako K; Yoshikawa K; Kurebayashi J; Toi M; Noda M
Oncotarget; 2016 Dec; 7(50):82158-82169. PubMed ID: 27058625
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
Mishra NK; Guda C
Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
[TBL] [Abstract][Full Text] [Related]
16. HOXA9, ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: array-based DNA methylation and expression profiling.
Kim YJ; Yoon HY; Kim JS; Kang HW; Min BD; Kim SK; Ha YS; Kim IY; Ryu KH; Lee SC; Kim WJ
Int J Cancer; 2013 Sep; 133(5):1135-42. PubMed ID: 23436614
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy.
Hartmann O; Spyratos F; Harbeck N; Dietrich D; Fassbender A; Schmitt M; Eppenberger-Castori S; Vuaroqueaux V; Lerebours F; Welzel K; Maier S; Plum A; Niemann S; Foekens JA; Lesche R; Martens JW
Clin Cancer Res; 2009 Jan; 15(1):315-23. PubMed ID: 19118060
[TBL] [Abstract][Full Text] [Related]
18. A novel molecular link between HOXA9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis.
Gonçalves CS; Xavier-Magalhães A; Martins EP; Pinto AA; Pires MM; Pinheiro C; Reis RM; Sousa N; Costa BM
Mol Oncol; 2020 Jun; 14(6):1224-1241. PubMed ID: 31923345
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
20. Identification of methylation sites and signature genes with prognostic value for luminal breast cancer.
Xiao B; Chen L; Ke Y; Hang J; Cao L; Zhang R; Zhang W; Liao Y; Gao Y; Chen J; Li L; Hao W; Sun Z; Li L
BMC Cancer; 2018 Apr; 18(1):405. PubMed ID: 29642861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]